Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Reid G. Adler currently holds 24,050 shares of VistaGen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reid G. Adler has been a net buyer of VTGN stock. They have purchased $51.0K and sold $0 worth of shares.
Reid G. Adler's most recent insider trade was on Jun 30, 2025, when they sold 7,541 shares at $1.70 per share.
Reid G. Adler serves as Executive at VistaGen Therapeutics, Inc. (VTGN). They have executed 6 insider transactions totaling $51.0K over their tenure at the company.
Reid G. Adler holds the position of Executive at VistaGen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Reid G. Adler has shown a buying trading pattern, with $51.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Reid G. Adler was on Aug 17, 2022, when they purchased $51.0K worth of VTGN shares. This transaction involved 300,000 shares at $0.17 per share.
Reid G. Adler currently owns 24,050 shares of VistaGen Therapeutics, Inc. (VTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Reid G. Adler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Reid G. Adler has 6 Form 4 filings on record as an insider at VistaGen Therapeutics, Inc..
Set alerts for Reid G. Adler and 40,000+ other insiders.